SK Bioscience (302440 KS): An Attractive Pure-Play on Vaccines- Both COVID and Non-COVID
SK Bioscience’s near-term growth will be driven by CMO contract of Novavax COVID-19 vaccine. The company’s rich non-COVID pipeline and global...
366 Views
Korea M&A Recap in 2021 - A Leapfrog Year
2021 has been a leapfrog year in terms of major M&As in Korea. Some of the largest M&A deals in 2022 could include Hanon Systems, Bodyfriend,...
523 Views
BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst
In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...
258 Views
EuBiologics (206650 KS): Cashing on Vaccine Business
Eubiologics is on a stable growth path, driven by increasing demand of its oral cholera vaccine business. Upcoming commercialization of COVID-19...
987 Views
The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?
The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.
690 Views